Ginkgo Bioworks

Ginkgo Bioworks

HQ Country
United States
Filtered by:
Ginkgo Bioworks
Company
Topic
Show
 
2021
21 Jun 2021

Plant-Based Meat 2021-2031

IDTechEx Report: Dr Michael Dent
13 May 2021

Cultured Meat 2021-2041: Technologies, Markets, Forecasts

IDTechEx Report: Dr Michael Dent
24 Mar 2021

Merck KGaA (Cultured Meat)

Merck
25 Feb 2021

Carbon Capture, Utilization, and Storage (CCUS) 2021-2040

IDTechEx Report: Dr Michael Dent
2020
30 Sep 2020

Cemvita Factory

Cemvita Factory is a technology start-up that uses synthetic biology to develop carbon negative technologies. The company has three primary applications - carbon capture, utilization and storage (CCUS), biomining, and biomanufacturing in space. In September 2020, IDTechEx Technology Analyst Dr Michael Dent spoke with Cemvita Factory CEO Moji Karimi about the company's activities in CCUS.
26 Aug 2020

Biostimulants and Biopesticides 2021-2031: Technologies, Markets and Forecasts

IDTechEx Report: Dr Michael Dent
28 Jul 2020

Feeding the World with Genetic Technologies: Technologies and Policies

Dr Michael Dent shares some of the research from the brand new IDTechEx report, "Genetic Technologies in Agriculture 2020-2030".
2 Jul 2020

Marrone Bio Innovations

Marrone Bio Innovations is a Californian company that produces a range of biologically derived pesticides and fertilizers that can be used as effective alternatives to synthetic agrochemicals, without the damage to the environment. In June 2020, IDTechEx Analyst Dr Michael Dent spoke with founder and CEO of Marrone Bio Innovations, Dr Pam Marrone.
4 Jun 2020

Genetic Engineering in Agriculture 2021-2031

IDTechEx Report: Dr Michael Dent
9 Apr 2020

Joyn Bio

Joyn Bio is a $100 million joint venture between chemicals giant Bayer and synthetic biology unicorn Ginkgo Bioworks. It is working to develop nitrogen fixing microbes that can be used to replace or supplement synthetic fertilisers.
2018
30 Oct 2018

New tools for the rapid genetic engineering of mammalian cells

Ginkgo Bioworks announced the opening of Bioworks4, its latest biological engineering foundry. Bioworks4 will for the first time enable Ginkgo to apply its automated, high-throughput process to the engineering of mammalian cell genomes, which are essential for pharmaceutical research and manufacturing.
19 Jul 2018

Synthetic Biology 2018

IDTechEx Report: Dr Nadia Tsao
2 Jun 2018

Ginkgo Bioworks

Ginkgo Bioworks designs microbial organisms for customers across multiple markets, including flavours and fragrances, cosmetic ingredients, crop treatments, carbon mitigation and pharma.
Included are: